Merck to stop phase 3 HYPERION trial evaluating Winrevair early and move to final analysis: Rahway, New Jersey Friday, January 31, 2025, 10:00 Hrs [IST] Merck, known as MSD outsid ...
Nicox SA (Euronext Growth Paris: FR0013018124, ALCOX), an international ophthalmology company, today announced a presentation ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today the Phase 3 HYPERION study evaluating WINREVAIR (sotatercept-csrk) versus placebo (both in combination with ...
Campaign encourages the use of low-dose aspirin to help reduce the risk of preeclampsia and the complications that come with ...
How Genetic Factors Are Associated with Behavioral Side Effects of GLP-1 Weight Loss Medication Glucagon-like peptide 1 ...
The FDA upgraded a recall of Lay's classic potato chips in Oregon and Washington to the highest level of severity, warning of potentially serious consequences from eating the product due to undeclared ...
The World Health Organization's (WHO) recent recommendation to replace regular table salt with lower-sodium salt substitutes ...
El Mundo on MSN6d
The neuroscientist behind the biological traces of mental health: "We have to discover the mysteries hidden in the brain"From her laboratory at the University of Cambridge, Camilla Nord seeks to provide biological answers to the brain changes ...
Some Civil Society Organizations (CSOs) in Ghana are calling on the government to reconsider its decision to remove the tax ...
Dementia must be explicitly integrated into NCD frameworks, standing alongside conditions such as cancer, diabetes, and ...
Monash University researchers have revealed how the gut—and what we eat—regulates high blood pressure, opening the door to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback